Cognitive impairment in Parkinson's disease
Jeremy Cosgrove1, Jane Elizabeth Alty1, Stuart Jamieson2
1Department of Neurology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK Hull York Medical School, University of York, York, UK.
Postgraduate Medical Journal
|March 28, 2015
Summary
Parkinson's disease (PD) often leads to cognitive impairment, with dementia affecting over 80% of patients within 20 years. Mild cognitive impairment (PD-MCI) in PD may have distinct subtypes requiring tailored management.
Area of Science:
- Neurology
- Neuroscience
- Cognitive Science
Background:
- Cognitive impairment is a key non-motor symptom in Parkinson's disease (PD).
- Longitudinal studies show PD dementia affects over 50% within 10 years and 80% within 20 years.
- Mild cognitive impairment (PD-MCI) is identifiable at diagnosis and is a risk factor for PD dementia.
Purpose of the Study:
- To explore the potential for distinct subtypes within PD-MCI.
- To understand the varying pathophysiologies and prognoses of PD-MCI.
- To inform management strategies for cognitive impairment in PD.
Main Methods:
- Review of longitudinal cohort studies on PD cognitive impairment.
- Analysis of pathological correlates of PD dementia (Lewy bodies, Alzheimer's pathology).
- Examination of neurotransmitter system alterations in PD-related cognitive changes.
Main Results:
- PD-MCI may comprise distinct subtypes with different underlying causes and outcomes.
- Lewy body deposition and Alzheimer's-related pathology are significant contributors to PD dementia.
- Neurotransmitter system dysfunction underlies behavioral and cognitive changes in PD.
Conclusions:
- Recognizing PD-MCI subtypes is crucial for accurate prognosis and treatment.
- A multidisciplinary approach is essential for managing cognitive impairment in Parkinson's disease.
- Effective communication with patients and families is vital for care.
Related Concept Videos
01:15Parkinson's Disease: Overview
2.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:37Neural Regulation
45.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.1K
01:30Dementia
728
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
728
01:30Negative and Cognitive Symptoms of Schizophrenia
1.1K
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
1.1K